In parallel of these experiments and in a mouse model of depression, we also report that the antidepressant-/anxiolytic-like activities of the SSRI fluoxetine is associated with a decrease in the phosphorylation level of Cx43 in the hippocampus. Here, GJA1 is linked to major depressive disorder.